Aptus Capital Advisors, LLC Milestone Pharmaceuticals Inc. Transaction History
Aptus Capital Advisors, LLC
- $12.7 Billion
- Q3 2025
A detailed history of Aptus Capital Advisors, LLC transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 210,200 shares of MIST stock, worth $433,012. This represents 0.0% of its overall portfolio holdings.
Number of Shares
210,200Holding current value
$433,012% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MIST
# of Institutions
68Shares Held
38.4MCall Options Held
111KPut Options Held
270K-
Adage Capital Partners Gp, L.L.C. Boston, MA6.98MShares$14.4 Million0.02% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA5.12MShares$10.6 Million10.26% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$10.2 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.22MShares$6.64 Million0.22% of portfolio
-
Morgan Stanley New York, NY2.97MShares$6.12 Million0.0% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $61.8M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...